Cough Medication for Upper Viral Cold
For an uncomplicated upper respiratory viral infection (URI) in adults, ipratropium bromide inhaler is the only medication with substantial evidence for cough suppression, while commonly used over-the-counter cough suppressants and expectorants are not recommended due to lack of proven efficacy. 1
Key Recommendation Based on Guidelines
The ACCP evidence-based guidelines are clear and definitive about cough treatment in viral URIs:
Ipratropium bromide (inhaled anticholinergic) is the only recommended agent for URI-related cough with Grade A recommendation (fair evidence, substantial benefit) 1
Central cough suppressants (codeine, dextromethorphan) are NOT recommended for URI cough - Grade D recommendation (good evidence, no benefit) 1
Peripheral cough suppressants have limited efficacy in URI and are not recommended - Grade D recommendation 1
Expectorants and mucolytics (including guaifenesin) are not recommended for cough suppression - Grade D recommendation 1
Why Most OTC Medications Don't Work
The evidence is surprisingly negative for commonly purchased medications:
A comprehensive Cochrane review found no good evidence for or against OTC cough medicines in acute cough, including antitussives, expectorants, antihistamines, and combination products 2
Newer "non-sedating" antihistamines are relatively ineffective for common cold symptoms 3
Guaifenesin (the most common expectorant) was specifically studied and found ineffective 1
What May Have Limited Benefit
If ipratropium is not available or tolerated, consider:
First-generation antihistamine/decongestant combinations (e.g., brompheniramine + pseudoephedrine) showed more rapid improvement in cough compared to placebo in one study, likely by treating post-nasal drip 3
Naproxen (NSAID) decreased cough in experimentally induced rhinovirus infection by reducing inflammation 3
Important Clinical Caveats
The desire to "suppress AND expectorate" reflects a common misconception - these are opposing goals. The evidence shows:
Productive cough in simple viral URI is uncommon in healthy adults - most URI cough is dry and non-productive 4
If truly productive cough exists, this may indicate bacterial superinfection (bronchitis) rather than simple URI, requiring different evaluation
Viral URIs increase cough sensitivity through inflammatory mediators affecting airway sensory nerves, not through mucus production requiring expectoration 3
Practical Algorithm
For dry, irritating URI cough:
- First-line: Ipratropium bromide inhaler
- Alternative: First-generation antihistamine/decongestant (if post-nasal drip present)
- Consider: Naproxen for anti-inflammatory effect
For productive cough with significant sputum:
- Reassess diagnosis - may not be simple viral URI
- Consider bacterial bronchitis if sputum is purulent or symptoms persist beyond typical viral course
Avoid:
- Codeine or dextromethorphan for URI cough
- Guaifenesin or other expectorants
- Combination OTC cough syrups with multiple ingredients
Bottom Line
Most patients seeking cough medication for viral colds are purchasing ineffective products. The evidence strongly supports using ipratropium bromide as the only medication with proven benefit, while counseling patients that viral URI cough typically resolves in 2-3 weeks without specific pharmacologic intervention 4. The widespread use of OTC cough suppressants and expectorants is not supported by quality evidence 2.